28, reported that the frequency of CD68+ cells correlates to interim‐PET results. In contrast, Agur et al. 29 reported that CD68 counts correlate to the initial tumor mass and residual tumor size, but not to interim PET result and PFS. This evidence concerns the gene CD68 and neoplasm.